These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29746610)
1. Modelling the complexity of heart failure with preserved ejection fraction. O'Gallagher K; Shah AM Cardiovasc Res; 2018 Jun; 114(7):919-921. PubMed ID: 29746610 [No Abstract] [Full Text] [Related]
2. [The role of oxidative stress in amiodaron toxicity, in left ventricular dysfunction of hypertensive patients and in heart failure with preserved ejection fraction]. Vereckei A Orv Hetil; 2015 Nov; 156(47):1921-5. PubMed ID: 26568108 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis. Bouthoorn S; Valstar GB; Gohar A; den Ruijter HM; Reitsma HB; Hoes AW; Rutten FH Diab Vasc Dis Res; 2018 Nov; 15(6):477-493. PubMed ID: 30037278 [TBL] [Abstract][Full Text] [Related]
4. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction. Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659 [TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of heart failure with normal ejection fraction. Maciver DH; Townsend M Heart; 2008 Apr; 94(4):446-9. PubMed ID: 17483129 [TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function. Johansson I; Dahlström U; Edner M; Näsman P; Rydén L; Norhammar A Diab Vasc Dis Res; 2018 Nov; 15(6):494-503. PubMed ID: 30176743 [TBL] [Abstract][Full Text] [Related]
8. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction. Alla F; Al-Hindi AY; Lee CR; Schwartz TA; Patterson JH; Adams KF Am Heart J; 2007 Jun; 153(6):1074-80. PubMed ID: 17540212 [TBL] [Abstract][Full Text] [Related]
10. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction. Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119 [TBL] [Abstract][Full Text] [Related]
11. Reduced arteriovenous oxygen difference in heart failure with preserved ejection fraction patients: Is the muscle oxidative phenotype certainly involved? Montero D; Lundby C Eur J Prev Cardiol; 2017 Jul; 24(11):1157-1160. PubMed ID: 28429959 [No Abstract] [Full Text] [Related]
12. Genetic predisposition in patients with hypertension and normal ejection fraction to oxidative stress. Fazakas Á; Szelényi Z; Szénási G; Nyírő G; Szabó PM; Patócs A; Tegze N; Fekete BC; Molvarec A; Nagy B; Jakus J; Örsi F; Karádi I; Vereckei A J Am Soc Hypertens; 2016 Feb; 10(2):124-32. PubMed ID: 26778769 [TBL] [Abstract][Full Text] [Related]
13. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction. Lam CS Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570 [TBL] [Abstract][Full Text] [Related]
14. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball. Tschöpe C; Van Linthout S; Kherad B Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481 [TBL] [Abstract][Full Text] [Related]
15. Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction. Greene SJ; Vaduganathan M; Gheorghiade M Eur J Heart Fail; 2017 Jul; 19(7):870-872. PubMed ID: 28464398 [No Abstract] [Full Text] [Related]
16. Heart failure with preserved ejection fraction: a precursor of heart failure with reduced ejection fraction or a distinct syndrome? Miani D; Badano LP; De Biaggio P; Albanese MC; Ghidina M; Proclemer A; Fioretti P Int J Cardiol; 2011 May; 149(1):139-40. PubMed ID: 21376409 [No Abstract] [Full Text] [Related]
17. [Comparative data charasteristic of laboratory examination of patients with chronic heart failure of ishemic origin with systolic left ventricular dysfunction and preserved left ventricular ejection fraction]. Diudina IO; Ponomar'ova TV; Parashcheniuk LP Lik Sprava; 2012; (3-4):47-52. PubMed ID: 23356137 [TBL] [Abstract][Full Text] [Related]
18. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT). Carson P; Johnson G; Fletcher R; Cohn J J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276 [TBL] [Abstract][Full Text] [Related]
19. [Heart failure with preserved left ventricular ejection fraction]. Petutschnigg J; Edelmann F Internist (Berl); 2019 Sep; 60(9):925-942. PubMed ID: 31432196 [TBL] [Abstract][Full Text] [Related]
20. Congestion in acute heart failure with reduced vs. preserved left ventricular ejection fraction: differences, similarities and remaining gaps. Bistola V; Polyzogopoulou E; Ikonomidis I; Parissis J Eur J Heart Fail; 2018 Apr; 20(4):748-750. PubMed ID: 29251810 [No Abstract] [Full Text] [Related] [Next] [New Search]